Skip to main content
Top
Published in: BMC Cancer 1/2020

01-12-2020 | Breast Cancer | Research article

A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities

Authors: Heling Bao, Limin Wang, Matthew Brown, Mei Zhang, Katherine Hunt, Jiangli Di, Zhenping Zhao, Shu Cong, Jing Fan, Liwen Fang, Linhong Wang

Published in: BMC Cancer | Issue 1/2020

Login to get access

Abstract

Background

Organized breast and cervical cancer screening programme could only provide services at no cost for a fraction of socioeconomic-deprived women in China and other low-resource countries, however, little evidence exists for whether such a programme effectively affect the participation and inequalities at the population level.

Methods

We used individual-level data from a nationally cross-sectional survey in 2014–2015 for breast and cervical cancer screening participation. Data for intervention and comparison grouping were from 2009 to 2014 national breast and cervical cancer screening programme, and counties covered by the programme were divided into intervention group. We assessed the impact of the intervention on the participation rates and the magnitude of inequalities with two approaches: multivariable multilevel logistic regressions adjusting for individual- and region-level covariates; and a difference analysis combined with propensity score matching that estimated the average intervention effect.

Results

Of 69,875 included women aged 35–64 years, 21,620 were classified into the intervention group and 43,669 into the comparison group for breast cancer screening; and 31,794 into the intervention group, and 33,682 into the comparison group for cervical cancer screening. Participation rate was higher in intervention group than comparison group for breast cancer screening (25.3, 95% confidential interval [CI], 22.8–27.7%, vs 19.1, 17.4–20.7%), and cervical cancer screening (25.7, 23.8–27.7%, vs 21.5, 19.6–23.5%), respectively. Intervention significantly increased the likelihood of participation for both breast cancer and cervical cancer screening in overall women, rural women and urban women, whereas the effect was significantly higher in rural women than urban women. The average intervention effect on the participation rate was an increase of 7.5% (6.7–8.2%) for breast cancer screening, and 6.8% (6.1–7.5%) for cervical cancer screening, respectively. The inequalities were significantly decreased by 37–41% (P < 0.001) between rural and urban, however, were slightly decreased or even increased in terms of age, education status, and household income.

Conclusions

Organized breast and cervical cancer screening programme targeting for a fraction of women could increase the participation rates at population level, however, it could not significantly affect socioeconomic-introduced inequalities. Further studies are need to conduct time-series analyses and strengthen the causal correlation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MF MI, Allen C, Hansen G. Woodbrook R et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1:505–27.CrossRef Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MF MI, Allen C, Hansen G. Woodbrook R et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1:505–27.CrossRef
2.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefPubMed
3.
go back to reference Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K. Breast-cancer screening--viewpoint of the IARC working group. N Engl J Med. 2015;372:2353–8.PubMedCrossRef Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K. Breast-cancer screening--viewpoint of the IARC working group. N Engl J Med. 2015;372:2353–8.PubMedCrossRef
5.
go back to reference Arnold M, Renteria E, Conway DI, Bray F, Van Ourti T, Soerjomataram I. Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century. Cancer Causes Control. 2016;27:999–1007.PubMedCrossRef Arnold M, Renteria E, Conway DI, Bray F, Van Ourti T, Soerjomataram I. Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century. Cancer Causes Control. 2016;27:999–1007.PubMedCrossRef
6.
go back to reference Adams EK, Breen N, Joski PJ. Impact of the National Breast and cervical Cancer early detection program on mammography and pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer. 2007;109:348–58.PubMedCrossRef Adams EK, Breen N, Joski PJ. Impact of the National Breast and cervical Cancer early detection program on mammography and pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer. 2007;109:348–58.PubMedCrossRef
7.
go back to reference Bucchi L, Baldacchini F, Mancini S, et al. Estimating the impact of an organised screening programme on cervical cancer incidence: a 26-year study from northern Italy. Int J Cancer. 2019;144:1017–26.PubMed Bucchi L, Baldacchini F, Mancini S, et al. Estimating the impact of an organised screening programme on cervical cancer incidence: a 26-year study from northern Italy. Int J Cancer. 2019;144:1017–26.PubMed
8.
go back to reference Van Dyne EA, Hallowell BD, Saraiya M, et al. Establishing baseline cervical Cancer screening coverage - India, 2015-2016. MMWR Morb Mortal Wkly Rep. 2019;68(1):14–9.PubMedCrossRef Van Dyne EA, Hallowell BD, Saraiya M, et al. Establishing baseline cervical Cancer screening coverage - India, 2015-2016. MMWR Morb Mortal Wkly Rep. 2019;68(1):14–9.PubMedCrossRef
9.
go back to reference Arrossi S, Paolino M, Laudi R, et al. Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy demonstration project in Argentina: a population-based, before-and-after retrospective cohort study. Lancet Glob Health. 2019;7:e772–e83.PubMedCrossRef Arrossi S, Paolino M, Laudi R, et al. Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy demonstration project in Argentina: a population-based, before-and-after retrospective cohort study. Lancet Glob Health. 2019;7:e772–e83.PubMedCrossRef
10.
go back to reference Ueda Y, Sobue T, Morimoto A, et al. Evaluation of a free-coupon program for cervical cancer screening among the young: a nationally funded program conducted by a local government in Japan. J Epidemiol. 2015;25:50–6.PubMedCrossRef Ueda Y, Sobue T, Morimoto A, et al. Evaluation of a free-coupon program for cervical cancer screening among the young: a nationally funded program conducted by a local government in Japan. J Epidemiol. 2015;25:50–6.PubMedCrossRef
11.
go back to reference Tabuchi T, Hoshino T, Nakayama T, Ito Y, Ioka A, Miyashiro I, Tsukuma H. Does removal of out-of-pocket costs for cervical and breast cancer screening work? A quasi-experimental study to evaluate the impact on attendance, attendance inequality and average cost per uptake of a Japanese government intervention. Int J Cancer. 2013;133:972–83.PubMedCrossRef Tabuchi T, Hoshino T, Nakayama T, Ito Y, Ioka A, Miyashiro I, Tsukuma H. Does removal of out-of-pocket costs for cervical and breast cancer screening work? A quasi-experimental study to evaluate the impact on attendance, attendance inequality and average cost per uptake of a Japanese government intervention. Int J Cancer. 2013;133:972–83.PubMedCrossRef
12.
go back to reference Fan LF, Kathrin SW, Li JJ, Jessica SL, Diamne MF, Yu KD, Chen WQ, Saho ZM, Paul EG. Breast cancer in China. Lancet Oncol. 2014;15:70567–9.CrossRef Fan LF, Kathrin SW, Li JJ, Jessica SL, Diamne MF, Yu KD, Chen WQ, Saho ZM, Paul EG. Breast cancer in China. Lancet Oncol. 2014;15:70567–9.CrossRef
13.
go back to reference Tao N, Lu HZ, Shen Y, Chen WZ. The research on the cervical cancer prevention and treatment in the past 23-years. Shanghai Med. 1984;7:338–42. Tao N, Lu HZ, Shen Y, Chen WZ. The research on the cervical cancer prevention and treatment in the past 23-years. Shanghai Med. 1984;7:338–42.
14.
go back to reference Di J, Rutherford S, Chu C. Review of the cervical Cancer burden and population-based cervical Cancer screening in China. Asian Pac J Cancer Prev. 2015;16:7401–7.PubMedCrossRef Di J, Rutherford S, Chu C. Review of the cervical Cancer burden and population-based cervical Cancer screening in China. Asian Pac J Cancer Prev. 2015;16:7401–7.PubMedCrossRef
15.
go back to reference Zhang D, Unschuld PU. China's barefoot doctor: past, present, and future. Lancet. 2008;372:1865–7.PubMedCrossRef Zhang D, Unschuld PU. China's barefoot doctor: past, present, and future. Lancet. 2008;372:1865–7.PubMedCrossRef
16.
go back to reference Wang B, He M, Wang L, Engelgau MM, Zhao W, Wang L. Breast Cancer screening among adult women in China, 2010. Prev Chronic Dis. 2013;10:130–6.CrossRef Wang B, He M, Wang L, Engelgau MM, Zhao W, Wang L. Breast Cancer screening among adult women in China, 2010. Prev Chronic Dis. 2013;10:130–6.CrossRef
17.
go back to reference Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399–424.CrossRef Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399–424.CrossRef
19.
go back to reference Bao H, Zhang L, Wang L, Zhang M, Zhao Z, Fang L, Cong S, Wang L. Significant variations in the cervical cancer screening rate in China by individul-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med. 2018;7:2089–100.PubMedPubMedCentralCrossRef Bao H, Zhang L, Wang L, Zhang M, Zhao Z, Fang L, Cong S, Wang L. Significant variations in the cervical cancer screening rate in China by individul-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med. 2018;7:2089–100.PubMedPubMedCentralCrossRef
21.
go back to reference Farzadfar F, Murray CJ, Gakidou E, et al. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet. 2012;379:47–54.PubMedCrossRef Farzadfar F, Murray CJ, Gakidou E, et al. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet. 2012;379:47–54.PubMedCrossRef
22.
go back to reference Mackenbach JP, Stirbu I, Roskam AJ, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358:2468–81.PubMedCrossRef Mackenbach JP, Stirbu I, Roskam AJ, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358:2468–81.PubMedCrossRef
23.
go back to reference Ma L, Ren WH, Zhao YX, et al. Cost-effectiveness of optimized ultrasound-based breast cancer screening for Chinese rural women in 2015. Chin Cancer. 2019;28:891–5. Ma L, Ren WH, Zhao YX, et al. Cost-effectiveness of optimized ultrasound-based breast cancer screening for Chinese rural women in 2015. Chin Cancer. 2019;28:891–5.
24.
go back to reference Luo XM, Song L, Wu JL, et al. Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013. Chin J Prev Med. 2016;50:346–50. Luo XM, Song L, Wu JL, et al. Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013. Chin J Prev Med. 2016;50:346–50.
25.
go back to reference Levano W, Miller JW, Leonard B, Bellick L, Crane BE, Kennedy SK, Haslage NM, Hammond W, Tharpe FS. Public education and targeted outreach to underserved women through the National Breast and cervical Cancer early detection program. Cancer. 2014;16:2591–6.CrossRef Levano W, Miller JW, Leonard B, Bellick L, Crane BE, Kennedy SK, Haslage NM, Hammond W, Tharpe FS. Public education and targeted outreach to underserved women through the National Breast and cervical Cancer early detection program. Cancer. 2014;16:2591–6.CrossRef
26.
go back to reference Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, Wethers B, Stokes-Townsend GA. Implementation of the National Breast and cervical Cancer early detection program: the beginning. Cancer. 2014;120:2540–8.PubMedCrossRef Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, Wethers B, Stokes-Townsend GA. Implementation of the National Breast and cervical Cancer early detection program: the beginning. Cancer. 2014;120:2540–8.PubMedCrossRef
27.
go back to reference Benard VB, Royalty J, Saraiya M, Rockwell T, Helsel W. The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women. Cancer Causes Control. 2015;26:713–9.PubMedPubMedCentralCrossRef Benard VB, Royalty J, Saraiya M, Rockwell T, Helsel W. The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women. Cancer Causes Control. 2015;26:713–9.PubMedPubMedCentralCrossRef
28.
go back to reference Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, Melillo S, Carvalho M, Taplin S, Bastani R, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med. 2012;43:97–118.PubMedCrossRef Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, Melillo S, Carvalho M, Taplin S, Bastani R, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med. 2012;43:97–118.PubMedCrossRef
29.
go back to reference Peitzmeier SM, Khullar K, Potter J. Effectiveness of four outreach modalities to patients overdue for cervical cancer screening in the primary care setting: a randomized trial. Cancer Causes Control. 2016;27:1081–91.PubMedCrossRef Peitzmeier SM, Khullar K, Potter J. Effectiveness of four outreach modalities to patients overdue for cervical cancer screening in the primary care setting: a randomized trial. Cancer Causes Control. 2016;27:1081–91.PubMedCrossRef
30.
go back to reference Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ. 2009;338:b2025.PubMedPubMedCentralCrossRef Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ. 2009;338:b2025.PubMedPubMedCentralCrossRef
31.
go back to reference Palencia L, Espelt A, Rodriguez-Sanz M, et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol. 2010;39:757–65.PubMedCrossRef Palencia L, Espelt A, Rodriguez-Sanz M, et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol. 2010;39:757–65.PubMedCrossRef
32.
go back to reference Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G Jr, et al. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol. 2015;16:1405–38.PubMedCrossRef Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G Jr, et al. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol. 2015;16:1405–38.PubMedCrossRef
33.
go back to reference Lantz PM, Mullen J. The National Breast and cervical Cancer early detection program: 25 years of public health service to low-income women. Cancer Causes Control. 2015;26:653–6.PubMedCrossRef Lantz PM, Mullen J. The National Breast and cervical Cancer early detection program: 25 years of public health service to low-income women. Cancer Causes Control. 2015;26:653–6.PubMedCrossRef
34.
go back to reference Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, Andrae B. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer. 2009;45:2671–8.PubMedCrossRef Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, Andrae B. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer. 2009;45:2671–8.PubMedCrossRef
35.
go back to reference Brown ML, Klabunde CN, Cronin KA, White MC, Richardson LC, McNeel TS. Challenges in meeting healthy people 2020 objectives for cancer-related preventive services, National Health Interview Survey, 2008 and 2010. Prev Chronic Dis. 2014;11:E29.PubMedPubMedCentralCrossRef Brown ML, Klabunde CN, Cronin KA, White MC, Richardson LC, McNeel TS. Challenges in meeting healthy people 2020 objectives for cancer-related preventive services, National Health Interview Survey, 2008 and 2010. Prev Chronic Dis. 2014;11:E29.PubMedPubMedCentralCrossRef
36.
go back to reference Xia CF, Hu SY, Xu XQ, et al. Projections upt ot 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health. 2019;4:3462–72.CrossRef Xia CF, Hu SY, Xu XQ, et al. Projections upt ot 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health. 2019;4:3462–72.CrossRef
37.
go back to reference Lewin S, Lavis JN, Oxman AD, et al. Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet. 2008;372:928–39.PubMedCrossRef Lewin S, Lavis JN, Oxman AD, et al. Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet. 2008;372:928–39.PubMedCrossRef
38.
go back to reference Simard EP, Fedewa S, Ma J, Siegel R, Jemal A. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer. 2012;118:5110–6.PubMedCrossRef Simard EP, Fedewa S, Ma J, Siegel R, Jemal A. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer. 2012;118:5110–6.PubMedCrossRef
39.
go back to reference White MC, Wong FL. Preventing premature deaths from breast and cervical cancer among underserved women in the United States: insights gained from a national cancer screening. Cancer Causes Control. 2015;26:805–9.PubMedPubMedCentralCrossRef White MC, Wong FL. Preventing premature deaths from breast and cervical cancer among underserved women in the United States: insights gained from a national cancer screening. Cancer Causes Control. 2015;26:805–9.PubMedPubMedCentralCrossRef
41.
go back to reference Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A. Using data to effectively manage a national screening program. Cancer. 2014;16:2575–83.CrossRef Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A. Using data to effectively manage a national screening program. Cancer. 2014;16:2575–83.CrossRef
42.
go back to reference DeGroff A, Royalty JE, Howe W, Buckman DW, Gardner J, Poister T, Hayes N. When performance management works: a study of the National Breast and cervical. Cancer. 2014;16:2566–74.CrossRef DeGroff A, Royalty JE, Howe W, Buckman DW, Gardner J, Poister T, Hayes N. When performance management works: a study of the National Breast and cervical. Cancer. 2014;16:2566–74.CrossRef
43.
go back to reference Plescia M, White MC. The National Prevention Strategy and breast cancer screening: scientific evidence for public health action. Am J Public Health. 2013;103:1545–8.PubMedPubMedCentralCrossRef Plescia M, White MC. The National Prevention Strategy and breast cancer screening: scientific evidence for public health action. Am J Public Health. 2013;103:1545–8.PubMedPubMedCentralCrossRef
44.
go back to reference DeGroff A, Cheung K, Dawkins-Lyn N, Hall MA, Melillo S, Glover-Kudon R. Identifying promising practices for evaluation: the National Breast and cervical Cancer early detection program. Cancer Causes Control. 2015;26:767–74.PubMedPubMedCentralCrossRef DeGroff A, Cheung K, Dawkins-Lyn N, Hall MA, Melillo S, Glover-Kudon R. Identifying promising practices for evaluation: the National Breast and cervical Cancer early detection program. Cancer Causes Control. 2015;26:767–74.PubMedPubMedCentralCrossRef
Metadata
Title
A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities
Authors
Heling Bao
Limin Wang
Matthew Brown
Mei Zhang
Katherine Hunt
Jiangli Di
Zhenping Zhao
Shu Cong
Jing Fan
Liwen Fang
Linhong Wang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-07686-4

Other articles of this Issue 1/2020

BMC Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine